drugset / Trial / NCT06126705
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
To evaluate the potential usefulness of 18F-AlF-FAPi-04 PET/CT for the diagnosis of primary and metastatic lesions in solid cancer.
Timeline
- Start
- 2023-07-18
- Primary completion
- 2024-05
- Completion
- 2024-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-AlF-FAPi-04 | Diagnostic / imaging agent | 3.7 mbq/kg | Intravenous |
| Subject | 18F-AlF-FAPi-04 | Diagnostic / imaging agent | 7.4 mbq/kg | Intravenous |
| Subject | 18F-FDG | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.